Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$13,591,941
+$3,105,644 QoQ
Shares Held
11,332
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.12%
of 13F equity value
Holder Rank
#1,084
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $29,476,537 across 10 Drug Manufacturers - General names. LLY ranks #1 (46.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
11,332 | $13,591,941 | |
| 2 | ABBV |
AbbVie Inc.
|
16,225 | $4,082,859 | |
| 3 | JNJ |
Johnson & Johnson
|
14,300 | $3,631,771 | |
| 4 | NVS |
Novartis AG
|
12,291 | $1,926,245 | |
| 5 | PFE |
Pfizer Inc
|
69,231 | $1,667,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,133 | $1,559,090 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,457 | $948,252 | |
| 8 | AMGN |
Amgen Inc
|
2,399 | $868,725 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,591,941 | 11,332 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $10,486,297 | 11,401 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $12,281,444 | 11,428 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $8,809,598 | 11,546 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $10,003,708 | 12,833 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $10,590,643 | 12,823 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,716,392 | 12,586 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $11,036,154 | 12,457 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,259,305 | 12,436 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,610,139 | 12,353 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,098,216 | 12,177 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,484,233 | 12,072 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,699,513 | 12,153 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,176,330 | 12,161 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,433,980 | 12,120 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,921,912 | 12,129 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,942,961 | 12,161 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,541,824 | 12,368 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,370,160 | 12,201 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,781,610 | 12,039 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,778,339 | 12,105 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,259,961 | 12,097 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,057,146 | 12,184 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,813,096 | 12,249 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,749,666 | 10,657 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,449,624 | 10,450 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||